Back to Search Start Over

Two differential pathways from double-negative to double-positive thymocytes.

Authors :
Matsumoto, K.
Yoshikai, Y.
Moroi, Y.
Asano, T.
Ando, T.
Nomoto, K.
Source :
Immunology; Jan1991, Vol. 72 Issue 1, p20-26, 7p
Publication Year :
1991

Abstract

Murine thymocytes are divided into four major populations on the basis of expression of CD4 and CD8 antigens. The bulk of evidence favours the view that CD4<superscript>-</superscript>CD8<superscript>-</superscript> cells can develop into CD4<superscript>-</superscript>CD8<superscript>+</superscript> and CD4<superscript>+</superscript>CD8<superscript>-</superscript> cells via the CD4<superscript>+</superscript>CD8<superscript>+</superscript> stage in the thymus. However, CD4<superscript>-</superscript>CD8<superscript>+</superscript> and CD4<superscript>+</superscript>CD8<superscript>-</superscript> thymocyte subsets contain not only CD3<superscript>+</superscript> mature cells but also CD3<superscript>-</superscript> immature cells, which seem to be intermediate cells between CD4<superscript>-</superscript>CD8<superscript>-</superscript> and CD4<superscript>+</superscript>CD8<superscript>+</superscript> cells. Here we demonstrate mouse strain differences in the proportion of immature single-positive thymocyte subsets in thymus at the steady or developing state. In C3H mice, immature CD4<superscript>+</superscript> CD8<superscript>-</superscript> is dominant in proportion over CD4<superscript>-</superscript>CD8<superscript>+</superscript> in foetal thymus and in donor-derived thymocytes at an early stage of bone marrow transplantation. On the other hand, immature CD4 CD8<superscript>+</superscript> is dominant over CD4<superscript>+</superscript>CD8<superscript>-</superscript> during T-cell development in the case of B10.BR mice. An intermediate pattern was shown in the case of Fi mice. Both of these immature single-positive subsets gave rise to doublepositive cells after 24 hr culture. These results suggest that there exist two distinct differential pathways; one is from CD4<superscript>-</superscript> CD8<superscript>-</superscript> cells to CD4<superscript>+</superscript> CD8<superscript>+</superscript> cells via CD4<superscript>-</superscript>CD8<superscript>+</superscript> cells, and another is via CD4<superscript>+</superscript>CD8<superscript>-</superscript> cells, and that an application of the 'CD8 pathway' or 'CD4 pathway' seems to be genetically destined by BM-derived cells but not by thymic stromal cells. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00192805
Volume :
72
Issue :
1
Database :
Complementary Index
Journal :
Immunology
Publication Type :
Academic Journal
Accession number :
13385080